Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells

Cancer Research

Volumn 58, Issue 18, 1998, Pages 4199-4205

  Gooch, Jennifer L ^a   Lee, Adrian V ^a   Yee, Douglas ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ESTRADIOL; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; SOMATOMEDIN C;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CELL GROWTH; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOREGULATION; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; CELL DIVISION; ESTRADIOL; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-4; OVARIAN NEOPLASMS; PACLITAXEL; RECEPTORS, ESTROGEN; RECEPTORS, INTERLEUKIN-4; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0032530501     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Stewart, A. J., Westley, B. R., and May, F. E. B. Modulation of the proliferative response of breast cancer cells to growth factors by oestrogen. Br. J. Cancer, 66: 640-548, 1992.
2. Thompson, E. W., Martin, M. B., Saceda, M., Clarke, R., Brunner, N., Lippman, M. E., and Dickson, R. B. Regulation of breast cancer cells by hormones and growth factors: effects on proliferation and basement membrane invasiveness. Horm. Res. (Basel), 32: 242-249, 1989.
3. Lorenzen, J., Lewis, C. E., McCraken, D., Horak, E., and Greenall, M. Human tumor-associated NK cells secrete increased amounts of interferon γ and interleukin-4. Br. J. Cancer, 64: 457-462, 1991.
4. Whitford, P., Mallon, E. A., George, W. D., and Campbell, A. M. Flow cytometric analysis of tumor infiltrating lymphocytes in breast cancer. Br. J. Cancer, 62: 971-975, 1990.
5. Toi, M., Bicknell, R., and Harris, A. L. Inhibition of colon and breast carcinoma cell growth by interleukin-4. Cancer Res., 55: 275-279, 1992.
6. Blais, Y., Gingras, S., Haagensen, D. E., Labrie, F., and Simard, J. Interleukin-4 and interleukin-13 inhibit estrogen-induced breast cancer cell proliferation and stimulate GCDFP-15 expression in human breast cancer cells. Mol. Cell. Endocrinol., 121: 11-18, 1996.
7. Obiri, N. I., Siegel, J. P., Varricchio, F., and Puri, R. K. Expression of high-affinity IL-4 receptors on human melanoma, ovarian and breast carcinoma cells. Clin. Exp. Immunol., 85: 148-155, 1994.
8. Paul, W. E. Interleukin-4: a prototypic immunoregulatory lymphokine. Blood, 77: 1859-1870, 1991.
9. Keegan, A. D., Nelms, K., White, M., Wang, L. M., Pierce, J. H., and Paul, W. E. An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth. Cell, 76: 811-820, 1994.
10. Ihle, J. N. Cytokine receptor signalling. Nature (Lond.), 377: 591-594, 1995.
11. Mat, I., Larche, M., Melcher, D., and Ritter, M. A. Tumour-associated up-regulation of the IL-4 receptor complex. Br. J. Cancer, 10 (Suppl.): 96-98, 1990.
12. Santin, A. D., Ioli, G. R., Hiserodt, J. C., Rose, G. S., Graf, M. R., Tocco, L. M., Lander, J. K., Eck, L. M., Burger, R. A., DiSaia, P. J., Pecorelli, S., and Granger, G. A. Development and characterization of an IL-4-secreting human ovarian carcinoma cell line. Gynecol. Oncol., 88: 230-239, 1995.
13. Golumbek, P. T., Lazenby, A. J., Levitsky, H. I., Jaffee, L. M., Karasuyama, H., Baker, M., and Pardoll, D. M. Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science (Washington DC), 254: 713-716, 1991.
14. Tepper, R. I., Pattengale, P. K., and Leder, P. Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell, 57: 503-512, 1989.
15. Obiri, N. I., Hillman, G. G., Haas, G. P., Sud, S., and Puri, R. K. Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4. J. Clin. Investig., 91: 88-93, 1993.
16. Topp, M. S., Papadimitriou, C. A., Eitelbach, F., Koenigsmann, M., Oelmann, E., Koehler, B., Oberberg, D., Reufi, B., Stein, H., Thiel, E., and Berdel, W. E. Recombinant human interleukin 4 has antiproliferative activity on human tumor cell lines derived from epithelial and nonepithelial histologies. Cancer Res., 55: 2173-2176, 1995.
17. 1 cell cycle progression in gastric carcinoma cells. Cancer Res., 54: 1113-1118, 1994.
18. Twentyman, P. R., and Luscombe, M. A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br. J. Cancer, 56: 279-285, 1987.
19. Chirgwin, J. M., Przybyla, A. I., MacDonald, R. J., and Rutter, W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry, 18: 5294-5299, 1979.
20. Figueroa, J. A., Lee, A. V., Jackson, J. G., and Yee, D. Proliferation of cultured human prostate cancer cells is inhibited by insulin-like growth factor binding protein-1: evidence for an IGF-II autocrine loop. J. Clin. Endocrinol. Metab., 80: 3476-3482, 1995.
21. Laborda, J. 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res., 19: 3998, 1991.
22. Badia, E., Duchesne, M. J., Fournier-Bidoz, S., Simar-Blanchet, A. E., Terouanne, B., Nicolas, J. C., and Pons, M. Hydroxytamoxifen induces a rapid and irreversible inactivation of an estrogenic response in an MCF-7-derived cell line. Cancer Res., 54: 5860-5866, 1994.
23. Rolling, C., Treton, D., Pellegrini, S,. Galanaud, P., and Richard, Y. IL4 and IL13 receptors share the γ c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells. FEBS. Lett., 393: 53-56, 1996.
24. Lai, S. Y., Molden, J., Liu, K. D., Puck, J. M., White, M. D., and Goldsmith, M. A. Interleukin-4-specific signal transduction events are driven by homotypic interactions of the interleukin-4 receptor α subunit. EMBO J., 15: 4506-4514, 1996.
25. Kammer, W., Lischke, A., Moriggl, R., Groner, B., Ziemiecki, A., Gurniak, C. B., Berg, L. J., and Friedrich, K. Homodimerization of interleukin-4 receptor α chain can induce intracellular signaling. J. Biol. Chem., 271: 23634-23637, 1996.
26. Palmer-Crocker, R. L., Hughes, C. C. W., and Pober, J. S. IL-4 and IL-13 activate the JAK2 tyrosine kinase and stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the γ c chain. J. Clin. Investig., 98: 604-609, 1996.
27. Spiegelberg, H., Beck, L., Kocher, H., Fanslow, W., and Lucas, A. Role of interleukin-4 in human immunoglobulin E formation in hum-PBL-SCID mice. J. Clin. Investig., 96: 711-717, 1994.
28. Fanslow, W., Spriggs, M., Rauch, C., Clifford, K., Macduff, B., Ziegler, S., Schooley, K., Mohler, K., March, C., and Armitage, R. Identification of a distinct low-affinity receptor for human interleukin-4 on pre-B cells. Blood, 81: 2998-3005, 1993.
29. Katzenellenbogen, B. S. Estrogen receptors: bioactivities and interactions with cell signaling pathways. Biol. Reprod., 54: 287-293, 1996.
30. Lee, A., Weng, C., Jackson, J., and Yee, D. Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells. J. Endocrinol., 152: 39-47, 1997.
31. Westley, B. R., and May, F. E. B. Role of insulin-like growth factors in steroid modulated proliferation. J. Steroid Biochem. Mol. Biol., 51: 1-9, 1994.
32. Cullen, K. J., Yee, D., Sly, W. S., Perdue, J., Hampton, B., Lippman, M. E., and Rosen, N. Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res., 50: 48-53, 1990.
33. Kulik, G., Kuppel, A., and Weber, M. J. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol. Cell. Biol., 17: 1595-1606, 1997.
34. Guvakova, M. A., and Surmacz, E. Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells. Exp. Cell Res., 231: 149-162, 1997.
35. Saunders, D., Lawrence, W., Christensen, C., Wappler, N., Raun, H., and Deppe, G. Paclitaxel-induced apoptosis in MCF-7 breast cancer cells. Int. J. Cancer, 70: 214-220, 1997.
36. Shah, G. M., Shah, R. G., and Poirier, G. G. Different cleavage pattern for poly(ADP-ribose) polymerase during necrosis and apoptosis in HL-60 cells. Biochem. Biophys. Res. Commun., 229: 838-844, 1996.
37. Robertson, N. M., Zangrilli, J., Fernandes-Alnemri, T., Friesen, P. D., Litwack, G., and Alnemri, E. S. Baculovirus P35 inhibits the glucocorticoid-mediated pathway of cell death. Cancer Res., 57: 43-47, 1997.
38. Costantino, A., Milazzo, G., Giorgino, F., Russo, P., Goldfine, I. D., Vigneri, R., and Belfiore, A. Insulin-resistant MDA-MB-231 human breast cancer cells contain a tyrosine kinase inhibiting activity. Mol. Endocrinol., 7: 1667-1676, 1993.
39. Crawford, R. M., Finbloom, D. S., Ohara, J., Paul, W. E., and Meltzer, M. S. B cell stimulatory factor-1 (interleukin-4) activates macrophages for increased tumoricidal activity and expression of Ia antigens. J. Immunol., 139: 135-141, 1987.
40. Mule, J. J., Smith, C. A., and Rosenberg, S. A. Interleukin-4 (B cell stimulatory factor) can mediate the induction of lymphokine-activated killer cell activity directed against fresh tumor cells. J. Exp. Med., 166: 792-797, 1987.
41. Jackson, J. G., White, M. F., and Yee, D. Insulin receptor-substrate-1 (IRS-1) is the predominant signaling molecule activated by insulin-like growth factor-I (IGF-I), insulin, and interleukin-4 (IL-4) in estrogen receptor positive human breast cancer cells. J. Biol. Chem., 273: 9994-10003, 1998.
42. Chin, Y., Kotagawa, M., Su, W-C., You, Z-H., Iwamoto, Y., and Fu, X-Y. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science (Washington DC), 272: 719-722, 1996.